No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

Cancer Monoclonal Antibody Market Cancer rates continue to rise, especially in aging populations and areas affected by pollution and lifest ...

Growth Drivers include demand for protein-based drugs, rise in chronic disease prevalence, precision medicine expansion, biotech advancements, and AI-driven design tools.Dublin, April 14, 2025 (GLOBE ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...

The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...

Despite its vital role in "kick-starting" the immune response, IgD is arguably the least understood antibody, with little known about how it might participate in other parts of the immune system. A ...

The FDA plans to reduce and potentially replace animal testing for developing monoclonal antibody therapies and other medications. AI-based computational models are expected to play a larger role ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies and ... of Environmental Health and Engineering at Johns Hopkins ...

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of animal testing The FDA announced that is going to be replacing animal testing ...